results

Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading…

5 months ago

Xinhua Silk Road: Annual Conference of Financial Street Forum 2025 concludes with fruitful results

BEIJING, Nov. 3, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum 2025 concluded on Thursday with a theme…

5 months ago

Derila Ergo Pillow Reviews Real Results, Benefits, Side Effects & Why the Derila Pillow Is Worth It for Pain-Free Sleep

New York City, NY, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Introduction – Is Poor Sleep Ruining Your Days? If you’ve…

5 months ago

Kia Announces 2025 Third Quarter Business Results

Kia posts Q3 revenue of KRW 28.69 trillion, up 8.2% Y/yQ3 global sales of 785,137 units, up 2.8% Y/yQ3 operating…

5 months ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

5 months ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

5 months ago

Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin

October 31, 2025 17:00 ET  | Source: Lucas GC Limited NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC…

6 months ago

AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025

October 31, 2025 16:33 ET  | Source: AMSC AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC® (NASDAQ: AMSC), a…

6 months ago

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered…

6 months ago

Tenable Announces Third Quarter 2025 Financial Results

Tenable Exceeds Q3 Revenue and Profit Expectations, Raises Full-Year Outlook Revenue of $252.4 million, year-over-year growth of 11%Calculated current billings…

6 months ago